HNRNPK and chronic myelogenous leukemia, BCR-ABL1 positive: Furthermore, hnRNP K has been considered as an prognostic marker in various types of cancer, including colorectal cancer [3], HNSCC [4], and chronic myeloid leukemia (CML) [5, 6].